M. Plone

发表

Blind rats are not profoundly impaired in the reference memory Morris water maze and cannot be clearly discriminated from rats with cognitive deficits in the cued platform task.

T. Schallert, D. Emerich, M. D. Lindner, 1997, Brain research. Cognitive brain research.

Validation of a rodent model of Parkinson's disease: Evidence of a therapeutic window for oral Sinemet

D. Emerich, M. D. Lindner, M. Plone, 1996, Brain Research Bulletin.

Double-blind study comparing doxercalciferol and placebo in vitamin D-replete CKD patients

C. Darwin, M. Plone, J. Cangiano, 2011 .

Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.

N. Chen, Xuemei Li, Xiaoqiang Ding, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Converting to doxercalciferol capsules from intravenous paricalcitol or doxercalciferol.

A. R. González, M. Plone, J. Hertel, 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.

P. Raggi, G. Chertow, S. Chasan-Taber, 2005, Arthritis and rheumatism.

Chronic morphine reduces pain-related disability in a rodent model of chronic, inflammatory pain.

C. Cain, M. D. Lindner, M. Plone, 1999, Experimental and clinical psychopharmacology.

Sevelamer Hydrochloride (Renagel®), a Nonabsorbed Phosphate‐Binding Polymer, Does Not Interfere with Digoxin or Warfarin Pharmacokinetics

Carlo Incerti, M. Plone, N. Watson, 2001, Journal of clinical pharmacology.

C. Cain, D. Emerich, M. D. Lindner, 1997, Physiology & Behavior.

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis

S. Fan, P. Kalra, S. Mitra, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Individual differences in the hotplate test and effects of habituation on sensitivity to morphine

D. Emerich, M. D. Lindner, M. Plone, 1996, PAIN®.

Dissociable long-term cognitive deficits after frontal versus sensorimotor cortical contusions.

C. Cain, D. Emerich, M. D. Lindner, 1998, Journal of neurotrauma.

The analgesic potential of intraventricular polymer-encapsulated adrenal chromaffin cells in a rodent model of chronic neuropathic pain.

D. Emerich, M. D. Lindner, J. Saydoff, 2000, Experimental and clinical psychopharmacology.

Somatic Delivery of Catecholamines in the Striatum Attenuate Parkinsonian Symptoms and Widen the Therapeutic Window of Oral Sinemet in Rats

D. Emerich, M. D. Lindner, M. Plone, 1997, Experimental Neurology.

A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.

W. Suki, S. Chasan-Taber, S. Moe, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts

M. D. Lindner, M. Plone, S. Winn, 1996, Brain Research.

Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats.

E. Doherty, D. Emerich, M. D. Lindner, 1997, Restorative neurology and neuroscience.

Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task

Dwaine F Emerich, J. Salamone, D. Emerich, 1997, Behavioural Brain Research.

Hyperparathyroidism and dialysis vintage.

G. Chertow, E. Slatopolsky, M. Plone, 2000, Clinical nephrology.

Sevelamer Hydrochloride (Renagel®), a Phosphate‐Binding Polymer, Does Not Alter the Pharmacokinetics of Two Commonly Used Antihypertensives in Healthy Volunteers

Carlo Incerti, M. Plone, S. Burke, 2001, Journal of clinical pharmacology.

Sevelamer, a Phosphate-Binding Polymer, is a Non-Absorbed Compound

J. Petersen, M. Plone, S. Burke, 2002, Clinical pharmacokinetics.

Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats

M. Hoane, C. Cain, D. Emerich, 1999, Behavioural Brain Research.

Novel dosage forms and regimens for sevelamer-based phosphate binders.

M. Plone, S. Burke, A. Duggal, 2006, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.

W. Suki, S. Chasan-Taber, S. Moe, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.

N. Chen, Xuemei Li, Xiaoqiang Ding, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Results of a randomized crossover study comparing once-daily and thrice-daily sevelamer dosing.

M. Plone, S. Burke, A. Blair, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of acute variation of dialysate calcium concentrations

S. Fan, P. Kalra, S. Mitra, 2009 .